BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 as Target for Breast Cancer Prevention and Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 4-14

Bentham Science Publishers

Access to resources Recommend Favorite

High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families

By Gronwald Jacek  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 111-113

Springer Publishing Company

Access to resources Recommend Favorite

Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

By Vogiatzi Paraskevi  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 213-216

Informa Healthcare

Access to resources Recommend Favorite

Leptomeningeal Carcinomatosis after Major Remission to Taxane-based Front-line Therapy in Patients with Advanced Breast Cancer

By Kosmas C.   Malamos N.A.   Tsavaris N.B.   Stamataki M.   Stefanou S.   Gregoriou A.   Rokana S.   Vartholomeou M.   Antonopoulos M.J.  

Journal of Neuro-Oncology, Vol. 56, Iss. 3, 2002-02 ,pp. : 265-273

Springer Publishing Company

Access to resources Recommend Favorite